Stem cells have been marketed to the public for their regenerative properties and their promise to revolutionize medicine. While only a few treatments are proven to be safe and effective, doctors are promoting the use of stem cells for diseases and conditions ranging from chronic pain to multiple sclerosis. At this event, experts discussed the landscape for stem cell therapies, and how unproven stem cell treatments can negatively impact patient health, clinical research and the perceptions of policymakers — ultimately slowing progress on future cell-based therapies.
This event was part of an annual policy lecture series co-sponsored by the Baker Institute Center for Health and Biosciences and the Texas Heart Institute. Support for the program has been provided by a grant from the George and Mary Josephine Hamman Foundation.
Follow BakerCHB on Twitter, and join the conversation online with #BakerHealth.
Agenda
12:00 p.m. — Welcome remarks and introduction
12:05 p.m. — Presentation
12:30 p.m. — Discussion and Q&A
Panelists
Zubin Master, Ph.D.
Associate Professor of Biomedical Ethics, Mayo Clinic
Emerson Perin, M.D., Ph.D.
Medical Director, Texas Heart Institute
Moderator
Kirstin R.W. Matthews, Ph.D.
Fellow in Science and Technology Policy, Baker Institute
